Methylation Mediated Silencing of miR-155 Suppresses the Development of Preeclampsia In Vitro and In Vivo by Targeting FOXO3
Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was perfor...
Saved in:
Published in | Mediators of inflammation Vol. 2022; pp. 1 - 20 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Hindawi
26.05.2022
John Wiley & Sons, Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was performed to evaluate miR-155 methylation levels. ELISA was performed to measure the levels of inflammatory cytokines and MMP2 in serum samples and cellular supernatants. HTR-8/SVneo and JEG-3 cells were transfected with miR-155 mimic and the inhibitor to establish the overexpressed miR-155 and silenced miR-155 cell models, respectively. Treatment with 5-Aza was performed to alter the DNA methylation level of miR-155. The PE rat model was established after subcutaneous injection of NG-nitro-L-arginine methyl ester. The CCK-8 assay, TUNEL staining, and Transwell assay were performed. Reverse transcription-quantitative PCR, Western blot analysis, and immunohistochemical assay were used to analyze related gene expression levels. The luciferase reporter assay was used to investigate the direct interaction between FOXO3 and miR-155. Results showed that miR-155 was remarkably upregulated and inversely correlated with the promoter methylation level in the placental tissue from PE patients. The in vitro experiments indicated that miR-155 decreased viability, migration, and invasion, but increased apoptosis in trophoblast cells. FOXO3 was confirmed as the target of miR-155. Transfection of the miR-155 inhibitor suppressed inflammation and oxidative stress, but elevated proliferation, migration, and invasion of trophoblast cells, which were abolished by 5-Aza treatment or cotransfection with si-FOXO3. In summary, our data suggested that methylation-mediated silencing of miR-155 can inhibit the apoptosis, inflammation, and oxidative stress of trophoblast cells by upregulating FOXO3. |
---|---|
AbstractList | Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was performed to evaluate miR-155 methylation levels. ELISA was performed to measure the levels of inflammatory cytokines and MMP2 in serum samples and cellular supernatants. HTR-8/SVneo and JEG-3 cells were transfected with miR-155 mimic and the inhibitor to establish the overexpressed miR-155 and silenced miR-155 cell models, respectively. Treatment with 5-Aza was performed to alter the DNA methylation level of miR-155. The PE rat model was established after subcutaneous injection of NG-nitro-L-arginine methyl ester. The CCK-8 assay, TUNEL staining, and Transwell assay were performed. Reverse transcription-quantitative PCR, Western blot analysis, and immunohistochemical assay were used to analyze related gene expression levels. The luciferase reporter assay was used to investigate the direct interaction between FOXO3 and miR-155. Results showed that miR-155 was remarkably upregulated and inversely correlated with the promoter methylation level in the placental tissue from PE patients. The in vitro experiments indicated that miR-155 decreased viability, migration, and invasion, but increased apoptosis in trophoblast cells. FOXO3 was confirmed as the target of miR-155. Transfection of the miR-155 inhibitor suppressed inflammation and oxidative stress, but elevated proliferation, migration, and invasion of trophoblast cells, which were abolished by 5-Aza treatment or cotransfection with si-FOXO3. In summary, our data suggested that methylation-mediated silencing of miR-155 can inhibit the apoptosis, inflammation, and oxidative stress of trophoblast cells by upregulating FOXO3.Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was performed to evaluate miR-155 methylation levels. ELISA was performed to measure the levels of inflammatory cytokines and MMP2 in serum samples and cellular supernatants. HTR-8/SVneo and JEG-3 cells were transfected with miR-155 mimic and the inhibitor to establish the overexpressed miR-155 and silenced miR-155 cell models, respectively. Treatment with 5-Aza was performed to alter the DNA methylation level of miR-155. The PE rat model was established after subcutaneous injection of NG-nitro-L-arginine methyl ester. The CCK-8 assay, TUNEL staining, and Transwell assay were performed. Reverse transcription-quantitative PCR, Western blot analysis, and immunohistochemical assay were used to analyze related gene expression levels. The luciferase reporter assay was used to investigate the direct interaction between FOXO3 and miR-155. Results showed that miR-155 was remarkably upregulated and inversely correlated with the promoter methylation level in the placental tissue from PE patients. The in vitro experiments indicated that miR-155 decreased viability, migration, and invasion, but increased apoptosis in trophoblast cells. FOXO3 was confirmed as the target of miR-155. Transfection of the miR-155 inhibitor suppressed inflammation and oxidative stress, but elevated proliferation, migration, and invasion of trophoblast cells, which were abolished by 5-Aza treatment or cotransfection with si-FOXO3. In summary, our data suggested that methylation-mediated silencing of miR-155 can inhibit the apoptosis, inflammation, and oxidative stress of trophoblast cells by upregulating FOXO3. Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was performed to evaluate miR-155 methylation levels. ELISA was performed to measure the levels of inflammatory cytokines and MMP2 in serum samples and cellular supernatants. HTR-8/SVneo and JEG-3 cells were transfected with miR-155 mimic and the inhibitor to establish the overexpressed miR-155 and silenced miR-155 cell models, respectively. Treatment with 5-Aza was performed to alter the DNA methylation level of miR-155. The PE rat model was established after subcutaneous injection of NG-nitro-L-arginine methyl ester. The CCK-8 assay, TUNEL staining, and Transwell assay were performed. Reverse transcription-quantitative PCR, Western blot analysis, and immunohistochemical assay were used to analyze related gene expression levels. The luciferase reporter assay was used to investigate the direct interaction between FOXO3 and miR-155. Results showed that miR-155 was remarkably upregulated and inversely correlated with the promoter methylation level in the placental tissue from PE patients. The in vitro experiments indicated that miR-155 decreased viability, migration, and invasion, but increased apoptosis in trophoblast cells. FOXO3 was confirmed as the target of miR-155. Transfection of the miR-155 inhibitor suppressed inflammation and oxidative stress, but elevated proliferation, migration, and invasion of trophoblast cells, which were abolished by 5-Aza treatment or cotransfection with si-FOXO3. In summary, our data suggested that methylation-mediated silencing of miR-155 can inhibit the apoptosis, inflammation, and oxidative stress of trophoblast cells by upregulating FOXO3. Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was performed to evaluate miR-155 methylation levels. ELISA was performed to measure the levels of inflammatory cytokines and MMP2 in serum samples and cellular supernatants. HTR-8/SVneo and JEG-3 cells were transfected with miR-155 mimic and the inhibitor to establish the overexpressed miR-155 and silenced miR-155 cell models, respectively. Treatment with 5-Aza was performed to alter the DNA methylation level of miR-155. The PE rat model was established after subcutaneous injection of NG-nitro-L-arginine methyl ester. The CCK-8 assay, TUNEL staining, and Transwell assay were performed. Reverse transcription-quantitative PCR, Western blot analysis, and immunohistochemical assay were used to analyze related gene expression levels. The luciferase reporter assay was used to investigate the direct interaction between FOXO3 and miR-155. Results showed that miR-155 was remarkably upregulated and inversely correlated with the promoter methylation level in the placental tissue from PE patients. The in vitro experiments indicated that miR-155 decreased viability, migration, and invasion, but increased apoptosis in trophoblast cells. FOXO3 was confirmed as the target of miR-155. Transfection of the miR-155 inhibitor suppressed inflammation and oxidative stress, but elevated proliferation, migration, and invasion of trophoblast cells, which were abolished by 5-Aza treatment or cotransfection with si-FOXO3. In summary, our data suggested that methylation-mediated silencing of miR-155 can inhibit the apoptosis, inflammation, and oxidative stress of trophoblast cells by upregulating FOXO3. Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in the inflammatory pathogenesis of PE. Placental tissues and peripheral blood were collected from all subjects. BSP detection analysis was performed to evaluate miR-155 methylation levels. ELISA was performed to measure the levels of inflammatory cytokines and MMP2 in serum samples and cellular supernatants. HTR-8/SVneo and JEG-3 cells were transfected with miR-155 mimic and the inhibitor to establish the overexpressed miR-155 and silenced miR-155 cell models, respectively. Treatment with 5-Aza was performed to alter the DNA methylation level of miR-155. The PE rat model was established after subcutaneous injection of NG-nitro-L-arginine methyl ester. The CCK-8 assay, TUNEL staining, and Transwell assay were performed. Reverse transcription-quantitative PCR, Western blot analysis, and immunohistochemical assay were used to analyze related gene expression levels. The luciferase reporter assay was used to investigate the direct interaction between FOXO3 and miR-155. Results showed that miR-155 was remarkably upregulated and inversely correlated with the promoter methylation level in the placental tissue from PE patients. The experiments indicated that miR-155 decreased viability, migration, and invasion, but increased apoptosis in trophoblast cells. FOXO3 was confirmed as the target of miR-155. Transfection of the miR-155 inhibitor suppressed inflammation and oxidative stress, but elevated proliferation, migration, and invasion of trophoblast cells, which were abolished by 5-Aza treatment or cotransfection with si-FOXO3. In summary, our data suggested that methylation-mediated silencing of miR-155 can inhibit the apoptosis, inflammation, and oxidative stress of trophoblast cells by upregulating FOXO3. |
Audience | Academic |
Author | Huang, Yulian Gu, Cunhua Luo, Xiaohua Guo, Xiaopei Zeng, Ying Cui, Shihong Pan, Ci Guo, Jing Yue, Jinjing |
AuthorAffiliation | 2 Henan Provincial Clinical Research Center for Perinatal Medicine, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052 Henan, China 1 Department of Obstetrics and Gynaecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052 Henan, China |
AuthorAffiliation_xml | – name: 1 Department of Obstetrics and Gynaecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052 Henan, China – name: 2 Henan Provincial Clinical Research Center for Perinatal Medicine, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052 Henan, China |
Author_xml | – sequence: 1 givenname: Xiaohua surname: Luo fullname: Luo, Xiaohua organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net – sequence: 2 givenname: Ci surname: Pan fullname: Pan, Ci organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net – sequence: 3 givenname: Xiaopei surname: Guo fullname: Guo, Xiaopei organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net – sequence: 4 givenname: Cunhua surname: Gu fullname: Gu, Cunhua organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net – sequence: 5 givenname: Yulian surname: Huang fullname: Huang, Yulian organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net – sequence: 6 givenname: Jing surname: Guo fullname: Guo, Jing organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net – sequence: 7 givenname: Ying surname: Zeng fullname: Zeng, Ying organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net – sequence: 8 givenname: Jinjing surname: Yue fullname: Yue, Jinjing organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net – sequence: 9 givenname: Shihong orcidid: 0000-0003-2971-558X surname: Cui fullname: Cui, Shihong organization: Department of Obstetrics and GynaecologyThe Third Affiliated Hospital of Zhengzhou UniversityZhengzhou450052 HenanChinazdsfy.net |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35664920$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1v0zAYhyM0xLrBjTOyxAUJsvkjdpLLpGkwqLSpiA3EzXKcN62rxA52WlSJPx5n7YBOgHyIHT_vY7_J7yg5sM5Ckjwn-IQQzk8ppvQ0oxwLSh4lE5IJkZJCkINkgktB05JxcpgchbDEGPMsK54kh4wLkZUUT5If1zAsNq0ajLPoGmqjBqjRjWnBamPnyDWoM5_SeBC6WfW9hxAgoGEB6C2soXV9B3YYqY8eQLeq64NRaGrRFzN4h5Stt4u1Q9UG3So_h2H0Xs6-ztjT5HGj2gDPds_j5PPlu9uLD-nV7P304vwq1bwgQ0qqSimqRQYa55WuMwo8TnhRMAUEmqIiLNdUFzonWOOiKXFDQRGimeB1IdhxMt16a6eWsvemU34jnTLy7oXzc6n8YHQLssKUq1zntMB5ltWkbAjUumJYENwAVdF1tnX1q6qLW7F9r9o96f6ONQs5d2tZEkGLjEXBq53Au28rCIPsTNDQtsqCWwVJRZ5hLHKOI_ryAbp0K2_jpxopRmnJcvKbmqvYgLGNi-fqUSrP83hvShguI3XyFyqOGjqjY6Sa-M_3C1782eivDu-zEwG6BbR3IXhopDbDXZCi2bSSYDkGVI4BlbuAxqI3D4ruvf_AX2_xhbG1-m7-T_8EUefv5Q |
CitedBy_id | crossref_primary_10_3389_fcell_2022_995462 crossref_primary_10_1016_j_placenta_2024_05_135 crossref_primary_10_1016_j_placenta_2024_09_018 crossref_primary_10_1038_s41598_025_94595_w crossref_primary_10_3389_fcell_2024_1494072 crossref_primary_10_1016_j_cellsig_2024_111506 crossref_primary_10_1016_j_cophys_2023_100647 crossref_primary_10_1186_s13062_024_00526_6 crossref_primary_10_1016_j_placenta_2023_11_010 crossref_primary_10_1186_s12884_025_07424_3 crossref_primary_10_1186_s12958_024_01248_0 crossref_primary_10_3390_biomedicines11102681 |
Cites_doi | 10.3892/mmr.2014.2214 10.1016/j.ajog.2017.11.568 10.1016/j.cbi.2013.11.010 10.1158/1078-0432.CCR-16-1025 10.1016/j.ejogrb.2013.05.005 10.1155/2014/103068 10.1016/j.ajog.2015.05.013 10.1080/10799893.2020.1870493 10.1158/0008-5472.CAN-07-6655 10.1007/s11906-017-0786-2 10.1007/s00011-019-01246-8 10.1016/j.arcmed.2014.10.003 10.1038/onc.2016.426 10.3892/ol.2018.7976 10.1161/HYPERTENSIONAHA.111.203489 10.1016/j.cell.2009.01.002 10.26355/eurrev_201909_19000 10.3892/mmr.2020.11050 10.3760/cma.j.cn112141-20200114-00039 10.1111/j.1365-2141.2011.08951.x 10.3892/ijo.2020.5057 10.1158/0008-5472.CAN-18-2545 10.1016/j.ajog.2010.01.057 10.1016/j.semcancer.2017.11.018 10.1016/j.freeradbiomed.2017.01.010 10.14670/HH-30.213 10.1097/MD.0000000000006509 10.1097/MIB.0000000000000009 10.1128/MCB.00410-18 10.1002/jcp.27291 10.1177/0960327120954252 10.1159/000505493 10.1055/s-0035-1570034 10.1038/nrg2540 10.1073/pnas.1607849113 10.1016/j.placenta.2012.07.012 10.1016/j.rbmo.2011.02.016 10.1016/j.gene.2018.01.049 |
ContentType | Journal Article |
Copyright | Copyright © 2022 Xiaohua Luo et al. COPYRIGHT 2022 John Wiley & Sons, Inc. Copyright © 2022 Xiaohua Luo et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 Copyright © 2022 Xiaohua Luo et al. 2022 |
Copyright_xml | – notice: Copyright © 2022 Xiaohua Luo et al. – notice: COPYRIGHT 2022 John Wiley & Sons, Inc. – notice: Copyright © 2022 Xiaohua Luo et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 – notice: Copyright © 2022 Xiaohua Luo et al. 2022 |
DBID | RHU RHW RHX AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.1155/2022/4250621 |
DatabaseName | Hindawi Publishing Complete Hindawi Publishing Subscription Journals Hindawi Publishing Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) PML(ProQuest Medical Library) Research Library Biological Science Database Research Library (Corporate) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database CrossRef |
Database_xml | – sequence: 1 dbid: RHX name: Hindawi Publishing Open Access url: http://www.hindawi.com/journals/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: Proquest Central Journals url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1466-1861 |
Editor | Lembo, Francesca |
Editor_xml | – sequence: 1 givenname: Francesca surname: Lembo fullname: Lembo, Francesca |
EndPage | 20 |
ExternalDocumentID | oai_doaj_org_article_b025a7c7280744d19f1edcb30610fe2a PMC9162843 A706121309 35664920 10_1155_2022_4250621 |
Genre | Journal Article |
GeographicLocations | Canada China United States--US |
GeographicLocations_xml | – name: China – name: Canada – name: United States--US |
GrantInformation_xml | – fundername: Key specialized research and development program in Henan province grantid: 212102310473 |
GroupedDBID | --- 0R~ 188 24P 29M 2WC 36B 4.4 53G 5GY 5VS 7X7 88E 8FE 8FH 8FI 8FJ 8G5 AAFWJ AAJEY ABDBF ABUWG ACCMX ACGFO ACIHN ACUHS ADBBV ADRAZ AEAQA AENEX AFKRA AFPKN AHMBA AINHJ ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC B0M BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CS3 DIK DU5 DWQXO E3Z EAD EAP EAS EBC EBD EBS EBX EMB EMK EMOBN EPL ESX F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 H13 HCIFZ HMCUK HYE IAO IGS IHR INH INR ITC KQ8 LK8 M1P M2O M48 M7P O5R O5S OK1 P2P PGMZT PHGZT PIMPY PQQKQ PROAC PSQYO RHU RHW RHX RNS RPM SV3 TR2 TUS UKHRP WOQ WOW ~8M AAYXX CITATION OVT PHGZM 2UF CAG CEFSP CGR CNMHZ COF CUY CVF ECM EIF EJD IL9 IPNFZ NPM OVD RIG TEORI UZ5 PMFND 3V. 7XB 8FK AAMMB AEFGJ AGXDD AIDQK AIDYY K9. MBDVC PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c581t-1bbaa2c64ec07bcd42e507b5883ae1ef8b137c2c8c710c08f90f2ea11c365d863 |
IEDL.DBID | 7X7 |
ISSN | 0962-9351 1466-1861 |
IngestDate | Wed Aug 27 01:30:30 EDT 2025 Thu Aug 21 17:51:55 EDT 2025 Fri Jul 11 02:14:31 EDT 2025 Fri Jul 25 12:04:12 EDT 2025 Tue Jun 17 22:02:37 EDT 2025 Tue Jun 10 21:03:42 EDT 2025 Thu Apr 03 07:09:45 EDT 2025 Tue Jul 01 01:13:37 EDT 2025 Thu Apr 24 23:01:16 EDT 2025 Wed Apr 16 06:26:22 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0 Copyright © 2022 Xiaohua Luo et al. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c581t-1bbaa2c64ec07bcd42e507b5883ae1ef8b137c2c8c710c08f90f2ea11c365d863 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Academic Editor: Francesca Lembo |
ORCID | 0000-0003-2971-558X |
OpenAccessLink | https://www.proquest.com/docview/2673229371?pq-origsite=%requestingapplication% |
PMID | 35664920 |
PQID | 2673229371 |
PQPubID | 2037497 |
PageCount | 20 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b025a7c7280744d19f1edcb30610fe2a pubmedcentral_primary_oai_pubmedcentral_nih_gov_9162843 proquest_miscellaneous_2674006750 proquest_journals_2673229371 gale_infotracmisc_A706121309 gale_infotracacademiconefile_A706121309 pubmed_primary_35664920 crossref_citationtrail_10_1155_2022_4250621 crossref_primary_10_1155_2022_4250621 hindawi_primary_10_1155_2022_4250621 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-05-26 |
PublicationDateYYYYMMDD | 2022-05-26 |
PublicationDate_xml | – month: 05 year: 2022 text: 2022-05-26 day: 26 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | Mediators of inflammation |
PublicationTitleAlternate | Mediators Inflamm |
PublicationYear | 2022 |
Publisher | Hindawi John Wiley & Sons, Inc Wiley |
Publisher_xml | – name: Hindawi – name: John Wiley & Sons, Inc – name: Wiley |
References | 22 23 24 25 26 27 28 29 F. Azizi (14) 2017; 6 30 31 10 32 11 33 12 34 13 35 36 15 37 16 38 B. Lamarca (4) 2010; 62 17 39 18 19 1 2 3 5 6 7 8 9 40 20 21 |
References_xml | – ident: 17 doi: 10.3892/mmr.2014.2214 – ident: 10 doi: 10.1016/j.ajog.2017.11.568 – ident: 2 doi: 10.1016/j.cbi.2013.11.010 – ident: 36 doi: 10.1158/1078-0432.CCR-16-1025 – ident: 1 doi: 10.1016/j.ejogrb.2013.05.005 – ident: 12 doi: 10.1155/2014/103068 – ident: 29 doi: 10.1016/j.ajog.2015.05.013 – ident: 40 doi: 10.1080/10799893.2020.1870493 – ident: 33 doi: 10.1158/0008-5472.CAN-07-6655 – ident: 5 doi: 10.1007/s11906-017-0786-2 – ident: 11 doi: 10.1007/s00011-019-01246-8 – ident: 3 doi: 10.1016/j.arcmed.2014.10.003 – ident: 39 doi: 10.1038/onc.2016.426 – ident: 20 doi: 10.3892/ol.2018.7976 – ident: 8 doi: 10.1161/HYPERTENSIONAHA.111.203489 – ident: 7 doi: 10.1016/j.cell.2009.01.002 – ident: 21 doi: 10.26355/eurrev_201909_19000 – ident: 35 doi: 10.3892/mmr.2020.11050 – ident: 25 doi: 10.3760/cma.j.cn112141-20200114-00039 – ident: 19 doi: 10.1111/j.1365-2141.2011.08951.x – ident: 26 doi: 10.3892/ijo.2020.5057 – ident: 30 doi: 10.1158/0008-5472.CAN-18-2545 – ident: 13 doi: 10.1016/j.ajog.2010.01.057 – ident: 38 doi: 10.1016/j.semcancer.2017.11.018 – ident: 28 doi: 10.1016/j.freeradbiomed.2017.01.010 – volume: 62 start-page: 105 issue: 2 year: 2010 ident: 4 article-title: The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia publication-title: Minerva Ginecologica – ident: 34 doi: 10.14670/HH-30.213 – ident: 15 doi: 10.1097/MD.0000000000006509 – ident: 22 doi: 10.1097/MIB.0000000000000009 – ident: 37 doi: 10.1128/MCB.00410-18 – ident: 27 doi: 10.1002/jcp.27291 – ident: 31 doi: 10.1177/0960327120954252 – volume: 6 start-page: 22 issue: 1 year: 2017 ident: 14 article-title: Evaluation of placental mir-155-5p and long non-coding RNA sONE expression in patients with severe pre-eclampsia publication-title: International Journal of Molecular and Cellular Medicine – ident: 24 doi: 10.1159/000505493 – ident: 6 doi: 10.1055/s-0035-1570034 – ident: 32 doi: 10.1038/nrg2540 – ident: 9 doi: 10.1073/pnas.1607849113 – ident: 18 doi: 10.1016/j.placenta.2012.07.012 – ident: 16 doi: 10.1016/j.rbmo.2011.02.016 – ident: 23 doi: 10.1016/j.gene.2018.01.049 |
SSID | ssj0005448 |
Score | 2.3961198 |
Snippet | Preeclampsia (PE) is a common pregnancy-related syndrome characterized by chronic immune activation. This study is aimed at exploring the role of miR-155 in... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref hindawi |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1 |
SubjectTerms | Analysis Animals Apoptosis Arginine B cells Cell adhesion & migration Cell culture Cell growth Cell Line, Tumor Cell Movement - genetics Cell proliferation Cell Proliferation - genetics Cholecystokinin Cytokines DNA methylation Enzyme-linked immunosorbent assay Female Forkhead Box Protein O3 - genetics Forkhead Box Protein O3 - metabolism FOXO3 protein Gelatinase A Gene expression Humans Immune response Inflammation Inflammation - metabolism Methylation MicroRNAs - genetics MicroRNAs - metabolism miRNA NG-Nitroarginine methyl ester Oxidative stress Pathogenesis Peripheral blood Placenta Placenta - metabolism Pre-eclampsia Pre-Eclampsia - metabolism Preeclampsia Pregnancy Rats Reverse transcription Transfection Trophoblasts - metabolism Womens health |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yoPgifltvlQgnPki55rPp4ykup7Ce6J3sW0nSlCtoe-zunQj-8c6k7bIV5V58bDO06cwk8xs6-Q0hB1wIp63lKQvWpjJomxa2ZqmoTWWKvDAyHqRdfNTHZ_LDUi13Wn1hTVhPD9wr7tBBULa5zyNri6xYUbNQeQdIl2V14BEaQcwbk6mxuAOyjrHMXSnM8PkheGemOZsEoMjTv92Nb55jHvyj-Rva_LNocicKze-SOwN8pEf9tO-RG6G9T24thh_kD8ivRQDN9_VtdBHbcISKfmnwaBEEKdrV9HvzOYXZUuznGZnD1xRAIN2pHkKpT6sQPHjLxbqx9H1LvzabVUdtW_UXVx11P-lpLCPH585PlifiITmbvzt9e5wODRZSrwzbpMw5MJPXMvgsd76SPAA8dMoYYQMLtXFM5J574wGH-MzURVbzYBnzQqvKaPGI7LVdG54QKhXyzDgvtRcyqzLnmNd1LkCq8ABJEvJ61HrpB_ZxbILxrYxZiFIl2qgcbJSQl1vpi5514x9yb9CAWxnkyo43wIPKwYPK6zwoIa_Q_CWuaJiSt8PBBPgw5MYqj3KEgRDri4TMJpKwEv1k-GBwoGsmPRu9qxw2jHXJdQ5bK5ITJuTFdhhfgEVwbeguo4xEdKFAm497Z9y-SAAslwWHkXziphPVTEfa5jzSiUOCABhFPP0futwnt_FTsbyC6xnZ26wuwzNAbRv3PC7Q34pZOx4 priority: 102 providerName: Directory of Open Access Journals – databaseName: Hindawi Publishing Open Access dbid: RHX link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEA96oPgifltdJcKJD1JsPpqmj6e4rMJ6oneybyFJU66g7bG7pwj-8c6k3Xo9FX1sM23TzCTzGzL5DSH7XAinrOUpC9amMiiblrZmqah1pcui1DIepF2-U4tj-XaVrwaSpM3vW_jg7TA85y_AtDKFB8Yvg4FhUL5Y_crkkLFIFoBxnpYiZ7v89gvPTjxPJOgfl-ErJxgAf2v-BDMvZkuecz_zG-T6gBvpQa_om-RSaG-Rq8thZ_w2-bEMMOR9YhtdxvoboaIfGzxTBN6JdjX90nxIobcUC3lGyvANBfRHz6UNodT7dQgezOR001j6pqWfmu26o7at-ouvHXXf6VHMH8f3zg9Xh-IOOZ6_Pnq1SIfKCqnPNdumzDnQj1cy-KxwvpI8AC50udbCBhZq7ZgoPPfaAwDxma7LrObBMuaFyiutxF2y13ZtuE-ozJFgxnmpvJBZlTnHvKoLAVKlByySkOe7UTd-oB3H6hefTQw_8tygjsygo4Q8HaVPe7qNv8i9RAWOMkiSHW-A4ZhhzhkHeM4WvoiEP7JiZc1Aiw6CJJbVgduEPEP1G5zK0CVvhxMJ8GNIimUOCsR_4OTLhMwmkjAF_aR5fzCgf3R6trMuM6wUG8NVAWsqshIm5MnYjB_A7Lc2dGdRRiKsyGE07_XGOH5IAB6XJYeWYmKmk6GZtrTNSeQRh8gAwIl48H-9f0iu4SVmTnA1I3vb9Vl4BIBs6x7H6fgTqXMqMA priority: 102 providerName: Hindawi Publishing – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELaqIhAXxLuhCzJSEQcUiJ9JDggVxKogLUXQRXuLbMehkUrS7m6BSvx4Zpzs0lQFjoknie2Zsb9Rxt8QssOFsNoYHjNvTCy9NnFuKhaLKiuzPM0zGQ7STj7oval8P1OzDbKqNtpP4OLS0A7rSU3nR89_npy9Aod_GRxeKYzf-QuwvUTjifIrsCelWMtgIv_whisZ6mgBXudxLhRbpcBfeHqwOQUO__VKffUQY-Qf9WVI9GJC5bkdanyT3OihJd3tbOEW2fDNbXJt0v88v0N-TTxopct9o5NQosOX9HONx45gA6NtRb_Vn2LoLcVan4FVfEEBINJzmUUo9XHuvQNLOl7Uhr5r6Jd6OW-pacru4ntL7Rk9CCnm-N7x_mxf3CXT8duDN3txX3whdipjy5hZCyp0WnqXpNaVknuAjlZlmTCe-SqzTKSOu8wBRnFJVuVJxb1hzAmtykyLe2SzaRu_RahUyEFjndROyKRMrGVOV6kAqdwBXInIs9WsF65nJscCGUdFiFCUKlBHRa-jiDxZSx93jBx_kXuNClzLII92uNHOvxa9WxYWIJ9JXRo4gWTJ8oqBFi3EUSypPDcReYrqL9D-oEvO9IcWYGDIm1XspggRAQfkERkNJMFL3aB5pzeg_3R6tLKuYuULBdcpLLtIXBiRx-tm_AAmyDW-PQ0yEpGHgtm83xnj-kMCILvMObSkAzMdTM2wpakPA9U4BA-AX8SDf3drm1zHQWBSBdcjsrmcn_qHgNWW9lFww98sZDY- priority: 102 providerName: Scholars Portal |
Title | Methylation Mediated Silencing of miR-155 Suppresses the Development of Preeclampsia In Vitro and In Vivo by Targeting FOXO3 |
URI | https://dx.doi.org/10.1155/2022/4250621 https://www.ncbi.nlm.nih.gov/pubmed/35664920 https://www.proquest.com/docview/2673229371 https://www.proquest.com/docview/2674006750 https://pubmed.ncbi.nlm.nih.gov/PMC9162843 https://doaj.org/article/b025a7c7280744d19f1edcb30610fe2a |
Volume | 2022 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bb9MwFLZgE4gXxJ1CqYw0xAOKFt9yeUIbrOpA3aayob5FtuOwSJCUtgMh8eM5x3W7BXF5iZT6qHF8PtufnePvELLDhTCJ1jxiTutIukRHua5YJKqszPI0z6Q_SDs-SkZn8t1UTcOG2yKEVa7HRD9Ql63FPfJdnqSAPVRvez37GmHWKPy6GlJoXCfbKF2GqE6n6WWIh_TZs4Cl8ygXiq0D35XCNT_fBbzGCWedKckr92_G5xvnuDL-Xv-Jf_4eRnllXhreIbcDoaR7KwTcJddcc4_cHIdP5vfJz7EDX6wi3ujYJ-ZwJf1Q42EjmLZoW9Ev9SSC2lLM8Om1xBcUaCG9Ek-EVidz5yzgZ7aoNT1s6Md6OW-pbsrVzbeWmh_01AeW4_8Oj6fH4gE5Gx6cvhlFIeVCZFXGlhEzBhxnE-lsnBpbSu6AMBqVZUI75qrMMJFabjMLzMTGWZXHFXeaMSsSVWaJeEi2mrZxjwmVCpVnjJWJFTIuY2OYTapUgFVugaT0yKt1qxc26JFjWozPhV-XKFWgj4rgox55sbGerXQ4_mK3jw7c2KB6tv-hnX8qQmcsDBA9ndrUKwHJkuUVAy8aWD2xuHJc98hLdH-BfRyqZHU4qgAvhmpZxV6KxBBm_7xH-h1L6Ju2U7wTAPSfSvfX6CrCELIoLgHfI883xfgADItrXHvhbSTyDQWt-WgFxs2DBBB1mXMoSTsw7TRNt6Spz73AOCwZgLWIJ_-u1lNyC18CQyl40idby_mFewYMbWkGvhsOyPb-wdHJBO7eHr4f-N0OuI5lBtfJaPoLS6I6BA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELZKEccL4mZhASO14gFFjY9cDwiVY7VLuy2CLdq3YDsOjQTJsrulqsRv4jcy4yTbBnE89THxKJl4xjPfOOMZQja4EDpUinvMKuVJGyovUTnzRB5ncRIlsXQHacd74fBAvp0G0zXysz0Lg2mVrU10hjqrDO6Rb_EwAt3D6m0vZt887BqFf1fbFhq1WuzYk2MI2RbPR69BvpucD95MXg29pquAZ4KYLT2mNfBmQmmNH2mTSW4BE-kgjoWyzOaxZiIy3MQGnK_x4zzxc24VY0aEQRaHAp57gVwEx-tjsBdNo9OUEum6dUFUwL1EBKxNtA8C3GPgW7A-_JCzjgt0nQJW_uDSIUbix8Wf8O7vaZtn_ODgOrnWAFi6XWvcDbJmy5vk8rj5RX-L_BhbkH2dYUfHrhGIzeiHAg83gZukVU6_Fu894JZiR1FXu3xBAYbSM_lLSPVubq0BfZ0tCkVHJf1YLOcVVWVWX3yvqD6hE5fIjs8d7E_3xW1ycC7CuEPWy6q09wiVAVa60UaGRkg_87VmJswjAVSJAVDUI8_aWU9NU_8c23B8SV0cFAQpyihtZNQjmyvqWV334y90L1GAKxqs1u1uVPPPabP4Uw3AUkUmcpWHZMaSnIEUNURrzM8tVz3yFMWfok0BloxqjkbAh2F1rnQ7QiAKaCPpkX6HEmyB6QxvNAr0H6b7rXaljclapKcLrEeerIbxBZiGV9rqyNFIxDcBzObdWhlXLxIQGMiEw0jUUdPO1HRHyuLQFTSHEAVQkrj_b7YekyvDyXg33R3t7TwgV_GDMI2Dh32yvpwf2YeADpf6kVuSlHw6bxvwC5ZjciQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVFRcEG8CBRapFQdkxfvw64BQSxs1lKRRaavczO56TS2BHZKUqhK_jF_HjB9pjXicekx2ZK93Zme-sb-dIWSDC6F9pbjDrFKOtL5yIpUyR6RhEkZBFMryIO1w5O8dy_cTb7JCfjZnYZBW2fjE0lEnhcF35D3uB2B7WL2tl9a0iPFO_-30m4MdpPBLa9NOozKRfXtxDunb_M1gB3S9yXl_9-jdnlN3GHCMF7KFw7SGeRpfWuMG2iSSW8BH2gtDoSyzaaiZCAw3oYFAbNwwjdyUW8WYEb6XhL6A694gqwFmRR2yur07Gh9eEkxk2bsLcgTuRMJjDe3e8_CNA-_BbnF9zloBsewbsIwON08xLz_P_oR-fydxXomK_Tvkdg1n6VZlf3fJis3vkbVh_cH-PvkxtGAJFd-ODsu2IDahHzM86gRBkxYp_ZodOjBbiv1Fy0rmcwqglF5hM6HUeGatAeudzjNFBzk9yRazgqo8qX58L6i-oEclrR2v2z-YHIgH5Pha1PGQdPIit48JlR7WvdFG-kZIN3G1ZsZPAwFSkQGI1CWvm1WPTV0NHZtyfInLrMjzYtRRXOuoSzaX0tOqCshf5LZRgUsZrN1d_lHMPse1K4g1wEwVmKCsQyQTFqUMtKghd2Nuarnqkleo_hg9DEzJqPqgBDwY1uqKtwKEpYA9oi5Zb0mCZzCt4Y3agP4z6fXGuuLagc3jy-3WJS-Xw3gDJOXltjgrZSSiHQ9W81FljMsbCUgTZMRhJGiZaWtp2iN5dlqWN4eEBTCTePLvab0ga7D_4w-D0f5TcgufBzkd3F8nncXszD4DqLjQz-s9Scmn63YDvwCDyXe_ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Methylation+Mediated+Silencing+of+miR-155+Suppresses+the+Development+of+Preeclampsia+In+Vitro+and+In+Vivo+by+Targeting+FOXO3&rft.jtitle=Mediators+of+inflammation&rft.au=Luo%2C+Xiaohua&rft.au=Pan%2C+Ci&rft.au=Guo%2C+Xiaopei&rft.au=Gu%2C+Cunhua&rft.date=2022-05-26&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=0962-9351&rft.eissn=1466-1861&rft.volume=2022&rft_id=info:doi/10.1155%2F2022%2F4250621&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0962-9351&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0962-9351&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0962-9351&client=summon |